Holen Sie sich die Stockscreener-App
172.81
0.78%
-1.36
Handel nachbörslich:
172.81
Natera Inc Aktie (NTRA) Neueste Nachrichten
Published on: 2025-10-14 14:53:56 - newser.com
Published on: 2025-10-14 13:40:45 - newser.com
Natera stock price target maintained at $200 by Canaccord on MRD leadership - Investing.com India
The 5 next big things in health and medicine for 2025 - Fast Company
Natera Shows Improved Relative Price Performance; Still Shy Of Benchmark - Investor's Business Daily
Natera to Host Investor Call on October 23, 2025 to Discuss ESMO Findings - BioSpace
Natera Inc. stock chart pattern explainedJuly 2025 Technicals & Entry Point Strategy Guides - newser.com
Why Natera Inc. stock remains on buy listsWeekly Market Outlook & Weekly High Return Stock Opportunities - newser.com
Is Natera Inc. stock positioned well for digital economyJuly 2025 Levels & Proven Capital Preservation Tips - newser.com
The Bull Case For Natera (NTRA) Could Change Following Breakthrough Study Results for Signatera Platform - Yahoo Finance
Natera Signatera Validation Study Published in JCO PO Shows Superior Prognostic Value in Testicular Cancer - Yahoo Finance
Phase 3 IMvigor011 results: Natera to discuss ESMO data on Oct. 23 investor call with lead PI - Stock Titan
Natera, Inc. (NTRA) Investor Outlook: Analyzing the 14.14% Potential Upside in Healthcare Diagnostics - DirectorsTalk Interviews
Natera (NTRA) Valuation: Exploring Upside as Investors Weigh Recent Performance and Long-Term Potential - Yahoo Finance
Natera to Present 14 Studies at ESMO, Including IMvigor011 Oral Presentation in Presidential Symposium - BioSpace
Signatera Validation and EXPAND Trial Progress Could Be a Game Changer for Natera (NTRA) - simplywall.st
Natera says to present 14 studies at Esmo, including Imvigor011 oral presentation - MarketScreener
Natera Says To Present 14 Studies At ESMO, Including Imvigor011 Oral Presentation - TradingView
Legal Advantage Investments Inc. Invests $591,000 in Natera, Inc. $NTRA - MarketBeat
waypoint wealth counsel Makes New Investment in Natera, Inc. $NTRA - MarketBeat
NeoGenomics rallies after court win in Natera patent dispute - MSN
Natera (NTRA) Valuation in Focus After New Clinical Advances in Cancer and Prenatal Testing - simplywall.st
Can volume confirm reversal in Natera Inc.Entry Point & Fast Moving Market Watchlists - newser.com
Natera's (NTRA) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Natera, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Natera, Inc. Forms Golden Cross, Signaling Potential Bullish Breakout Ahead - Markets Mojo
Natera, Inc. $NTRA Position Increased by Narwhal Capital Management - MarketBeat
QRG Capital Management Inc. Increases Position in Natera, Inc. $NTRA - MarketBeat
Natera Inc Stock Analysis and ForecastTrading Volume Surges & Compound Your Gains With Quality Stocks - earlytimes.in
Truist Financial Corp Purchases 4,525 Shares of Natera, Inc. $NTRA - MarketBeat
What drives Natera Inc stock priceDividend Yield Trends & Low Cost Portfolio Ideas - earlytimes.in
Chart based exit strategy for Natera Inc.2025 Market WrapUp & Safe Capital Growth Tips - newser.com
Is Natera Inc. building a consolidation base2025 Stock Rankings & Precise Swing Trade Entry Alerts - newser.com
Mirae Asset Global Investments Co. Ltd. Purchases 2,837 Shares of Natera, Inc. $NTRA - MarketBeat
How institutional ownership impacts Natera Inc. stockJuly 2025 Technicals & Fast Exit Strategy with Risk Control - newser.com
Natera's Enrollment Surge in EXPAND Trial Could Be a Game Changer for Natera (NTRA) - simplywall.st
Combining machine learning predictions for Natera Inc.Market Weekly Review & Weekly Chart Analysis and Trade Guides - newser.com
Natera, Inc. $NTRA Shares Purchased by ASR Vermogensbeheer N.V. - MarketBeat
Barclays Keeps Their Buy Rating on Natera (NTRA) - The Globe and Mail
Natera (NTRA): Exploring Valuation as Share Price Pulls Back Despite Strong Growth - simplywall.st
Natera (NTRA): Assessing Valuation Potential as Shares Enter a Quiet Phase - simplywall.st
Is Natera Inc. a candidate for recovery play2025 AllTime Highs & Accurate Trade Setup Notifications - newser.com
Natera Stock (NTRA) Opinions on EXPAND Trial Enrollment and Insider Sales - Quiver Quantitative
Natera (NASDAQ:NTRA) Insider Sells $479,970.00 in Stock - MarketBeat
Natera CEO Chapman sells $3.7m in stock By Investing.com - Investing.com Australia
Enrollment Tops 1,600 in Natera’s EXPAND Trial of Single Gene NIPT - BioSpace
Natera enrolls over 1,600 patients in EXPAND trial for fetal testing - Investing.com Nigeria
Natera (NASDAQ:NTRA) CFO Sells $403,666.55 in Stock - MarketBeat
Insider Sell: Solomon Moshkevich Sells 3,000 Shares of Natera In - GuruFocus
1.14%
0.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):